CSBR Logo

Champions Oncology, Inc. (CSBR) 

NASDAQ
Market Cap
$57.91M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
219 of 776
Rank in Industry
127 of 433

Largest Insider Buys in Sector

CSBR Stock Price History Chart

CSBR Stock Performance

About Champions Oncology, Inc.

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology …

Insider Activity of Champions Oncology, Inc.

Over the last 12 months, insiders at Champions Oncology, Inc. have bought $142,144 and sold $0 worth of Champions Oncology, Inc. stock.

On average, over the past 5 years, insiders at Champions Oncology, Inc. have bought $166,483 and sold $2.65M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Mendelson Daniel Newman (director) — $142,144.

The last purchase of 1,000 shares for transaction amount of $6,500 was made by Mendelson Daniel Newman (director) on 2024‑01‑12.

List of Insider Buy and Sell Transactions, Champions Oncology, Inc.

2024-01-12Purchasedirector
1,000
0.0071%
$6.50$6,500-26.88%
2024-01-11Purchasedirector
2,000
0.0147%
$6.27$12,540-21.74%
2024-01-10Purchasedirector
2,944
0.022%
$6.31$18,577-20.96%
2024-01-09Purchasedirector
3,000
0.0221%
$6.25$18,750-21.07%
2024-01-08Purchasedirector
1,000
0.0074%
$6.15$6,150-20.37%
2024-01-05Purchasedirector
2,000
0.0146%
$6.09$12,180-19.36%
2024-01-04Purchasedirector
3,000
0.0221%
$6.12$18,360-19.02%
2024-01-03Purchasedirector
500
0.0035%
$5.83$2,915-19.54%
2023-12-21Purchasedirector
2,500
0.0184%
$4.92$12,300+0.82%
2023-12-20Purchasedirector
2,100
0.015%
$4.82$10,122-0.20%
2023-12-19Purchasedirector
5,000
0.0384%
$4.75$23,750+5.31%
2023-10-11Purchasedirector
5,000
0.0385%
$6.40$32,000-18.15%
2023-10-10Purchasedirector
1,100
0.008%
$6.41$7,051-20.97%
2023-10-06Purchasedirector
1,530
0.0114%
$6.48$9,914-21.47%
2023-10-05Purchasedirector
2,000
0.0156%
$6.47$12,940-18.23%
2023-10-04Purchasedirector
5,000
0.0386%
$6.40$32,000-19.52%
2023-10-03Purchasedirector
2,500
0.019%
$6.30$15,750-19.27%
2023-09-29Purchasedirector
4,000
0.0294%
$6.16$24,640-17.71%
2023-09-28Purchasedirector
5,000
0.0379%
$6.22$31,100-15.63%
2023-09-27Purchasedirector
1,500
0.0115%
$5.95$8,925-11.16%

Insider Historical Profitability

76.5%
Mendelson Daniel Newmandirector
198625
1.4611%
$4.26302+54.24%
BROWN MICHAEL MAURICE10 percent owner
22281040
163.9059%
$4.2620
Battery Ventures IX, L.P.10 percent owner
22281040
163.9059%
$4.2620
ACKERMAN JOELdirector
1021731
7.5162%
$4.26101+66.02%
Morris RonnieCEO
858878
6.3182%
$4.26161+86.37%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Battery Management Corp$11.87M17.822.42M0%+$02.62
Nea Management Company Llc$8.4M12.611.71M0%+$00.04
Tocqueville Asset Management$3.35M5.04684,628+<0.01%+$245.000.05
Renaissance Technologies$611,000.000.92124,691-0.08%-$490.01<0.01
BlackRock$566,847.000.85115,683-0.36%-$2,028.60<0.0001
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.